Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Type
Public
HQ
Wayne, US
Founded
1995
Size (employees)
78 (est)-32%
Egalet was founded in 1995 and is headquartered in Wayne, US

Egalet Office Locations

Egalet has office in Wayne
Wayne, US

Egalet Metrics

Egalet Summary

Market capitalization

$118.8 m

Closing share price

$4.8
Egalet's current market capitalization is $118.8 m.

Egalet Financials

Egalet's revenue is $1.9 m in FY, 2014 which is a 91.6% decrease from the previous period.
FY, 2014FY, 2015

Revenue

$1.9 m$22.8 m

Revenue growth, %

1089.1%

Net Income

($43.2 m)($57.9 m)

Egalet Market Value History

Egalet Online Presence

Egalet Company Life

You may also be interested in